share_log

Medlive Technology Insider Lowered Holding By 58% During Last Year

Medlive Technology Insider Lowered Holding By 58% During Last Year

去年 Medlive Technology Insider 将持股量下调
Simply Wall St ·  2023/09/27 18:32

Viewing insider transactions for Medlive Technology Co., Ltd.'s (HKG:2192 ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in relation to shares purchased.

查看内部交易梅德利夫科技有限公司的S(HKG:2192)过去一年,我们看到内部人士是净卖家。这意味着,与购买的股票相比,内部人士出售的股票数量更多。

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

尽管就长期投资而言,内幕交易并不是最重要的事情,但我们会认为完全忽视内幕交易是愚蠢的。

View our latest analysis for Medlive Technology

查看我们对Medlive Technology的最新分析

The Last 12 Months Of Insider Transactions At Medlive Technology

Medlive Technology最近12个月的内幕交易

Over the last year, we can see that the biggest insider sale was by the VP, Deputy Head of Medical Information Science Research Unit & Executive Director, Lijun Tian, for HK$2.1m worth of shares, at about HK$14.13 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is HK$8.06. So it is hard to draw any strong conclusion from it. The only individual insider seller over the last year was Lijun Tian.

过去一年,我们可以看到,最大的内幕出售是董事副总裁兼医学信息科学研究部门副主管兼高管田丽君,以每股约14.13港元的价格购买了价值210万港元的股票。我们通常不喜欢看到内幕销售,但售价越低,我们就越担心。令人欣慰的是,此次出售的价格远远高于目前8.06港元的股价。因此,很难从中得出任何强有力的结论。去年唯一的个人内幕卖家是田丽君。

Lijun Tian ditched 200.00k shares over the year. The average price per share was CN¥13.60. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

田立军在过去一年里抛售了20万股股票。每股均价为13.60加元。你可以看到过去一年的内幕交易(由公司和个人),如下图所示。如果你想知道到底是谁卖了,卖了多少钱,什么时候卖的,只需点击下面的图表!

insider-trading-volume
SEHK:2192 Insider Trading Volume September 27th 2023
联交所:2023年9月27日内幕交易量2192

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些想要找到赢得投资免费最近有内幕收购的不断增长的公司名单可能就是合适的选择。

Insider Ownership Of Medlive Technology

Medlive Technology的内部人所有权

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.1% of Medlive Technology shares, worth about HK$62m, according to our data. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

看看一家公司的内部人持股总数,可以帮助你了解他们是否与普通股股东很好地结合在一起。通常,内部人持股越高,内部人就越有可能受到激励,建立长期的公司。根据我们的数据,内部人士持有Medlive Technology 1.1%的股份,价值约6200万港元。然而,我们确实注意到,内部人士可能通过私人公司或其他公司结构拥有间接利益。总体而言,这种所有权水平并不令人印象深刻,但肯定比什么都没有好!

So What Do The Medlive Technology Insider Transactions Indicate?

那么,Medlive Technology Insider交易表明了什么?

The fact that there have been no Medlive Technology insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by Medlive Technology insiders. But it's good to see that insiders own shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Medlive Technology. You'd be interested to know, that we found 1 warning sign for Medlive Technology and we suggest you have a look.

最近没有发生Medlive Technology的内幕交易,这一事实当然不会让我们感到困扰。我们不会从Medlive Technology内部人士的交易中获得太多鼓励。但看到内部人士持有该公司的股份是件好事。除了了解正在进行的内幕交易外,识别Medlive Technology面临的风险也是有益的。你会有兴趣知道的,我们发现1个对Medlive科技的警告标志我们建议你去看看。

But note: Medlive Technology may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:Medlive Technology可能不是最值得买入的股票。所以让我们来看看这个免费高净资产收益率和低负债的有趣公司名单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前只处理公开市场交易和私下处置直接权益,而不处理衍生工具交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发